Clinical trials: Ischem Heart Disease

Ischem Heart Disease, Primary Coronay Intervention

CHAOS Registry Study

• Unknown status
• Age: 18 to 100 years
• Observational study
• Pill or oral medicine

INTRODUCTION: About 6-8% of patients undergoing PCI have an indication for long-term oral anticoagulants (OACs) due to various conditions such as atrial fibrillation (AF), mechanical heart valves, or venous thromboembolism.

Conditions

Ischem Heart Disease, Primary Coronay Intervention, Oral Anticoagulants, Atrial Fibrillation

Trial name

CHAOS (NCT03558295)

Testing

Oral Anticoagulant

Where

Italy

Volunteers

1,000 people

Sponsor

A.O.U. Città della Salute e della Scienza